Interventional cardiology, peripheral vascular devices market expected to reach $31.5 billion in 2021
The global interventional cardiology and peripheral vascular devices market is expected to reach $31.47 billion in 2021, an increase from $21.83 billion in 2016, according to a new report from Research and Markets.
The projections amount to a compound annual growth rate of 7.1 percent.
The report defined the market as angioplasty balloons, angioplasty stents, catheters, endovascular aneurysm repair (EVAR) stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices and accessories.
The angioplasty stents category consists of drug-eluting stents, bare-metal stents and bioabsorbable stents. The report expects that drug-eluting stents will have the highest growth rate in this segment.
The catheters market consists of intravascular ultrasound/optical coherence tomography (IVUS/OCT), angiography catheters and guiding catheters. The report expects that IVUS/OCT will have the highest growth rate.
The EVAR stent grafts market consists of abdominal aortic aneurysms and thoracic aortic aneurysms. The report expects that abdominal aortic aneurysms will have the highest growth rate.
North America accounts for the largest geographic region for the interventional cardiology and peripheral vascular devices market, followed by Europe and Asia.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.